Kidney Tumor Clinical Trial
Official title:
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy - A Multicentre, Randomised, Controlled Trial
The primary objective is to determine if 3D modelling shortens total console operation time as a surrogate endpoint for clinical outcomes like perioperative complications and morbidity in robotic-assisted partial nephrectomy.
3DPN is a prospective, multicentre, randomised, controlled, two-armed, open trial to compare the 3D modelling with the 2D modelling in robotic-assisted partial nephrectomy. According to the randomisation the 3D or 2D modelling is used for patient information (before intervention) and for partial nephrectomy. A six-month follow-up visit is provided. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01950923 -
Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
|
Phase 1 | |
Withdrawn |
NCT01688414 -
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
|
N/A | |
Recruiting |
NCT05387863 -
Decision Aid (DA) for Renal Patients
|
N/A | |
Active, not recruiting |
NCT03819569 -
GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses
|
N/A | |
Recruiting |
NCT01967407 -
IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.
|
Phase 1/Phase 2 | |
Terminated |
NCT00960063 -
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
|
Phase 1 | |
Recruiting |
NCT05890781 -
Engineering Immune Organoids to Study Pediatric Cancer
|
N/A | |
Completed |
NCT05015179 -
Mixed Reality Technology in Laparoscopic Partial Nephrectomy
|
N/A | |
Completed |
NCT00019630 -
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
|
Phase 1 | |
Completed |
NCT01908166 -
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
|
N/A | |
Recruiting |
NCT05728957 -
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
|